Lupin informs about press release

25 Aug 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 25th August 2020 as regards receipt of U.S. FDA approval for the Company’s Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation, a generic version of ProAir® HFA. Generic Albuterol Sulphate MDI will be manufactured at the Company’s Indore (Unit III) facility in India. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2072.70 17.65 (0.86%)
11-Dec-2025 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.95
Dr. Reddys Lab 1270.50
Cipla 1501.55
Zydus Lifesciences 921.10
Lupin 2072.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×